Medinfo Logo

 
 
MastheadResources







Go to our search section.
Click here>
Need to contact us? If you are unable to find an answer to your question and would like to contact us, please email us or call

Resources

The following are provided as additional sources of information related to Novartis products.

A B C D E F G I J K L M N P R S T U V X Z

 

 

Lamisil* (terbinafine hydrochloride)
Antifungal Agent

*Lamisil is a registered trademark

 

 

Leqvio* (Inclisiran)
Interfering Ribonucleic Acid Proprotein convertase subtilisin kexin type 9 inhibitor

*LEQVIO is a trademark

 

 

Locametz* (gallium (68Ga) gozetotide)
Diagnostic Radiopharmaceutical Kit

*LOCAMETZ is a trademark

 

 

Lucentis* (ranibizumab injection)
Antineovascularisation agent

*Lucentis is a registered trademark

 

 

Lutathera* (lutetium (177Lu) oxodotreotide)
Antineovascularisation agent

*LUTATHERA is a registered trademark

 

 

Luxturna* (voretigene neparvovec)
Recombinant adeno-associated virus 2 vector-based gene therapy ATC S01XA27

*LUXTURNA is a registered trademark of Spark Therapeutics Inc., used under license by Novartis Pharmaceuticals Canada Inc.


Back to top

Use of this website is governed by our Terms of Use and Privacy Statement.
© Novartis Pharmaceuticals Canada Inc. 2012. All rights reserved.